✦ LIBER ✦

Erythroblastic transformation of Philadelphia chromosome (Ph1)-positive chronic myelogenous leukemia associated with marked chromosomal rearrangements

✍ Scribed by Naoki Sadamori; Shuichi Ikeda; Takaya Muta; Michito Ichimaru; Masako Matsunaga

Book ID: 119102541
Publisher: Elsevier Science
Year: 1981
Tongue: English
Weight: 379 KB
Volume: 3
Category: Article
ISSN: 0165-4608
DOI: 10.1016/0165-4608(81)90045-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evolution of karyotypes in philadelphia

Evolution of karyotypes in philadelphia (Ph1) chromosome-negative chronic myelogenous leukemia

✍ Uri Mintz; James Vardiman; Harvey M. Golomb; Janet D. Rowley 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 447 KB 👁 2 views

Application of FISH to complex chromosom

Application of FISH to complex chromosomal rearrangements associated with chronic myelogenous leukemia

✍ Beth A. Sullivan; Charles A. Schiffer; Shivanand R. Paril; Dennis Hulseberg; Jul 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 468 KB

Letter to the editor: Ph-positive chroni

Letter to the editor: Ph-positive chronic myelogenous leukemia with a 5q− chromosome abnormality terminating in erythroblastic crisis

✍ Taira Maekawa; Shinichi Misawa; Masafumi Taniwaki; Tatsuro Takino; Yoshiaki Sono 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Recurrent appearance of 14q+ chromosome

Recurrent appearance of 14q+ chromosome associated with lymphoid crisis of Ph-positive chronic myelogenous leukemia

✍ Jouji Hirata; Hiroshi Takatsuki; Tsukuru Umemura; Tatsuro Goto; Shingo Sadamura; 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 628 KB

Outcome of patients with Philadelphia ch

Outcome of patients with Philadelphia chromosome-positive chronic myelogenous leukemia post-imatinib mesylate failure

✍ Hagop Kantarjian; Susan O'Brien; Moshe Talpaz; Gautam Borthakur; Farhad Ravandi; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB 👁 1 views

## Abstract ## BACKGROUND. The prognosis of patients with chronic myelogenous leukemia (CML) after failure of imatinib mesylate therapy is not well documented. ## METHODS. The outcome of 420 patients with CML post‐imatinib failure (resistance‐recurrence in 374; toxicities in 46) were reviewed in

Philadelphia Chromosome-positive Chronic

Philadelphia Chromosome-positive Chronic Myelogenous Leukemia with Deleted Fusion of BCR and ABL Genes

✍ Ohyashiki, Kazuma ;Ohyashiki, Junko H. ;Iwabuchi, Hirotaka ;Tauchi, Tetsuzo ;Iwa 📂 Article 📅 1990 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 698 KB